1. Home
  2. SXT vs APLS Comparison

SXT vs APLS Comparison

Compare SXT & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SXT
  • APLS
  • Stock Information
  • Founded
  • SXT 1882
  • APLS 2009
  • Country
  • SXT United States
  • APLS United States
  • Employees
  • SXT N/A
  • APLS N/A
  • Industry
  • SXT Major Chemicals
  • APLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • SXT Industrials
  • APLS Health Care
  • Exchange
  • SXT Nasdaq
  • APLS Nasdaq
  • Market Cap
  • SXT 2.9B
  • APLS 3.3B
  • IPO Year
  • SXT N/A
  • APLS 2017
  • Fundamental
  • Price
  • SXT $74.29
  • APLS $19.94
  • Analyst Decision
  • SXT Buy
  • APLS Buy
  • Analyst Count
  • SXT 1
  • APLS 18
  • Target Price
  • SXT $85.00
  • APLS $45.59
  • AVG Volume (30 Days)
  • SXT 304.2K
  • APLS 2.1M
  • Earning Date
  • SXT 04-25-2025
  • APLS 05-06-2025
  • Dividend Yield
  • SXT 2.20%
  • APLS N/A
  • EPS Growth
  • SXT 33.03
  • APLS N/A
  • EPS
  • SXT 2.94
  • APLS N/A
  • Revenue
  • SXT $1,557,228,000.00
  • APLS $781,367,000.00
  • Revenue This Year
  • SXT $3.84
  • APLS $12.85
  • Revenue Next Year
  • SXT $4.39
  • APLS $20.78
  • P/E Ratio
  • SXT $25.74
  • APLS N/A
  • Revenue Growth
  • SXT 6.92
  • APLS 97.02
  • 52 Week Low
  • SXT $66.15
  • APLS $21.70
  • 52 Week High
  • SXT $82.99
  • APLS $58.12
  • Technical
  • Relative Strength Index (RSI)
  • SXT 52.27
  • APLS 30.79
  • Support Level
  • SXT $73.68
  • APLS $21.70
  • Resistance Level
  • SXT $76.00
  • APLS $23.23
  • Average True Range (ATR)
  • SXT 1.63
  • APLS 1.21
  • MACD
  • SXT 0.14
  • APLS -0.10
  • Stochastic Oscillator
  • SXT 42.47
  • APLS 2.58

About SXT Sensient Technologies Corporation

Sensient Technologies Corp manufactures and markets natural and synthetic colors, flavors, and other specialty ingredients. The company has a widespread network of facilities around the globe, and its customers operate across a variety of end markets. Sensient's offerings are predominantly applied to consumer-facing products, including food and beverage, cosmetics and pharmaceuticals, nutraceuticals, and personal care industries. The company's principal products are flavors, flavor enhancers, ingredients, extracts, and bionutrients, essential oils, dehydrated vegetables and other food ingredients, natural and synthetic food and beverage colors, and others. The company's three reportable segments were the Flavors & Extracts Group, the Color Group, and the Asia Pacific Group.

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

Share on Social Networks: